Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study - Quiz - MDSpire

Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study

  • By

  • Lukas Böck

  • Katharina Kerschan-Schindl

  • Martin Frossard

  • Stefan Hajdu

  • Richard Crevenna

  • Martina Anditsch

  • Gunar Stemer

  • Anna Antoni

  • July 3, 2026

  • 0 min

Share

Original Source(s)

Osteoporosis treatment gap prior to femoral fracture and prevalence of pharmacological risk factors: a prospective observational study

  • by Lukas Böck, Katharina Kerschan-Schindl, Martin Frossard, Stefan Hajdu, Richard Crevenna, Martina Anditsch, Gunar Stemer, Anna Antoni

  • July 3, 2026

Related Content

Side Effects: Sour Mouth, Lower BP

Acidic gum beat sugar-free at cranking out nitric oxide from beetroot juice — exactly backward from what test-tube studies predicted. Also this week: a sleep gene that ignores amyloid, and jackfruit sap moonlighting as a bone-building drug delivery system.

Unveiling the efficacy predictors and potential mechanisms of Semen Cuscutae against osteoporosis via machine learning and meta-analysis: a preclinical study

Research progress on the intervention of osteoporosis by Chinese herbal monomers based on the Nrf2/NF-κB/MAPK pathway